NCT00758719
Completed
Not Applicable
A Prospective Multicenter Lumbar Spine Fusion Study to Evaluate the Effectiveness of the Biomet Lumbar Spinal Fusion System
ConditionsDegenerative Disc Disease
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Degenerative Disc Disease
- Sponsor
- Zimmer Biomet
- Enrollment
- 53
- Locations
- 4
- Primary Endpoint
- Radiographic Fusion
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
The purpose of this study is to evaluate the effectiveness of the Biomet Lumbar Spinal Fusion System in patients undergoing lumbar fusion surgery.
Detailed Description
All subjects enrolled in this study will receive the The Biomet Osteobiologic Treatment System which is comprised of the SpF® Spine Fusion Stimulator and any or all of the following can be utilized in the study: any Pedicle Screw System, autograft and an Interbody Spacer
Investigators
Eligibility Criteria
Inclusion Criteria
- •The subject must, in the investigator's opinion, be psychosocially, mentally, and physically able to fully comply with this protocol including the required follow-up visits, the filling out of required forms, and have the ability to understand and give written informed consent.
- •The subject must be diagnosed with degenerative disc disease at up to 2 levels from L2-S1 inclusive and undergoing up to 2 level posterior lumbar spinal fusion surgery with or without anterior column fusion.
- •Subjects must be between 18 and 75 years of age.
- •The patient must be skeletally mature (epiphyses closed).
Exclusion Criteria
- •Subject is pregnant, lactating or interested in becoming pregnant during the duration of the study.
- •Any active litigation.
- •Subject is currently involved in another investigational study.
- •Subject has a history (present or past) of substance abuse (recreational drugs, prescription drugs or alcohol) that in the investigator's opinion may interfere with protocol assessments and/or with the subject's ability to complete the protocol required follow-up.
- •Subject is incarcerated.
- •More than 2 prior spine surgeries/revision surgeries or any previous spinal fusions at levels being currently treated.
- •Traumatic instability.
- •Any parathyroid or metabolic bone disease.
- •Any active malignancy.
- •Osteopenia/Osteoporosis - All subjects will be screened for osteoporosis using SCORE (Simple Calculated Osteoporosis Risk Estimation) with a threshold value of
Outcomes
Primary Outcomes
Radiographic Fusion
Time Frame: 12 Month
Secondary Outcomes
- Neurologic Assessment, Maintenance or improvement from baseline(12 Month)
- Narcotic Use(24 month)
- Visual Analog Scale (VAS) change from baseline(24 Months)
- Oswestry Disability Index change from baseline(24 Month)
- Time to return to normal activity(24 month)
- Short Form Health Survey (SF-36) % change from baseline(24 Month)
- Time to return to work(24 month)
Study Sites (4)
Loading locations...
Similar Trials
Terminated
Not Applicable
Interbody Systems: Post Market Clinical Follow-up StudyDegenerative Disc DiseaseNCT04911257K2M, Inc.28
Completed
Not Applicable
A Clinical Study of a Spine Fusion System in Vertebral Body Fusion SurgeryDisc Degenerative DiseaseSpondylolisthesisSpinal FractureSpinal DeformitySpinal StenosisSpinal TumorNCT02252185Johnson & Johnson Medical (Suzhou) Ltd.106
Completed
Not Applicable
A Study Comparing Fusion Rates of Two Lumbar Fusion ProceduresPseudoarthrosisSpinal StenosisSpondylolisthesisDegenerative Disc Disease (DDD)NCT01972256Baxano Surgical, Inc.60
Active, not recruiting
Not Applicable
Prospective Study of Thoracolumbar Spinal Fusion GraftLumbar Degenerative Disc DiseaseNCT02297256NYU Langone Health17
Completed
Not Applicable
INDEPENDENCE Spacer for Lumbar FusionDegenerative Disc DiseaseNCT02299323Globus Medical Inc30